Oncochain
Oncochain is revolutionizing cancer research by providing a robust platform for retrospective data curation and analytics. Their flagship product, Onco Abstrakt, enables healthcare providers to create operational patient data repositories for real-world data studies, facilitating the collection of anonymized data from multiple sources. The platform adheres to GDPR compliance and integrates the latest interoperability standards, making it a valuable tool for multi-centric academic studies and expediting scientific article publishing. With a recent grant from Innovation Norway, Oncochain is poised to enhance its AI capabilities, further solidifying its position in the oncology data landscape.
Oncochain
Oncochain is revolutionizing cancer research by providing a robust platform for retrospective data curation and analytics. Their flagship product, Onco Abstrakt, enables healthcare providers to create operational patient data repositories for real-world data studies, facilitating the collection of anonymized data from multiple sources. The platform adheres to GDPR compliance and integrates the latest interoperability standards, making it a valuable tool for multi-centric academic studies and expediting scientific article publishing. With a recent grant from Innovation Norway, Oncochain is poised to enhance its AI capabilities, further solidifying its position in the oncology data landscape.
TL;DR
What they do: Platform for collecting, curating and visualizing real-world oncology data (Onco Abstrakt)
Headquarters: Amsterdam, Netherlands
Founded: 2020
Employee count: 9
Recent grant / AI focus: Received a grant from Innovation Norway to enhance AI capabilities
Company Overview
Problem Domain
Real-world data (RWD) collection and analytics for oncology research and value-based cancer care.
Founded
2020
Industry
Healthtech / Oncology data
Funding Track Record
Latest disclosed round recorded on Nov 15, 2020 via Equity Crowdfunding (SeedBlink referenced in available summaries)